$ARMK

Aramark (ARMK): Results of Operations and Financial Condition

Aramark (ARMK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991armkq3fy2026.htm EX-99.1 Document For Immediate Release Inquiries: Felise Glantz Kissell (215) 409-7287 Kissell-Felise@aramark.com Gene Cleary (215) 409-7945 Cleary-Gene@aramark.com Aramark Reports Third Quarter Earnings YEAR-OVER-YEAR SUMMARY Note: As previously d

Original reporting
Published Aug 11, 2026, 10:34 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 11:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$ARMK
Bullish
medium confidence
Mentioned
$ARMK
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ARMKBullishHigh
01

Why it matters

The release combines quantified earnings and cash flow with a stated increase to fiscal 2026 organic revenue expectations, creating a direct catalyst for valuation and near-term positioning.

02

Market read

Earnings beat-style metrics (revenue, EPS, operating income/AOI) plus a guidance raise are the core tradable inputs for ARMK.

03

What to watch

Operating income and AOI benefited from supply chain efficiencies and cost management; if those benefits fade, the guidance raise may be harder to sustain.

Relevance 7/10Novelty 8/10Timing: pre-market today (8-K filed Aug 11, 2026)

Background

SEC Form 8-K Item 2.02 includes Aramark’s third quarter fiscal 2026 results and related commentary, including the impact of a 53rd week calendar shift.

Company-level read

Ticker impact

$ARMKBullishMedium confidence
Context

Aramark reported Q3 FY2026 revenue up 9% to $5.1B, GAAP EPS up 34% to $0.36, and raised fiscal 2026 organic revenue expectations.

Expected impact

Likely positive bias for the next session as traders price in stronger organic growth and margin/cash generation.

Evidence & confidence

This is a primary 8-K earnings release with quantified results (revenue, EPS, operating income/AOI, FCF) and a stated increase to fiscal 2026 organic revenue expectations, which are actionable for positioning.

Market effects

Strength in food, facilities, and hospitality services demand (including sports, healthcare, and education) may support sentiment for contract services peers.

Broad-based growth cited across U.S. and international geographies (Spain, Canada, U.K., Germany) suggests resilience beyond one region.

Hyperscaler and AI data center hospitality expansion (Aramark Nexus) links contract services demand to ongoing AI infrastructure buildout.

Counterpoint

The company attributes part of the quarter’s comparisons to a 53rd-week calendar shift; traders may discount the magnitude of underlying momentum versus reported growth.

Key entities

  • Aramark

    Reported Q3 FY2026 results, cash generation, and expansion of Aramark Nexus, and raised fiscal 2026 organic revenue expectations.

  • Aramark Nexus

    Premium hospitality services expansion tied to hyperscaler and AI data center sites, including a multi-year engagement mentioned in the release.

Related articles

$ARMKMedAI 8/10

Why Aramark (ARMK) Stock Is Up Today

Aramark (NYSE: ARMK) shares rose about 9.8% after the company reported better-than-expected Q3 2026 results. Revenue was $5.06B, up 9.3% year over year, and adjusted EPS was $0.52 above consensus. Free cash flow turned positive at $8.69M versus a $33.55M loss a year earlier, supporting investor sentiment.

$ARMKHighAI 9/10

Why is Aramark stock surging today?

Aramark (ARMK) shares rose about 8.3% after the company reported fiscal Q3 2026 adjusted EPS of $0.52 vs $0.48 consensus and revenue of $5.1B vs $4.92B forecast. Organic revenue grew 9% and adjusted operating income rose to $261M. Aramark raised FY26 organic revenue guidance to 9–10% and reaffirmed adjusted EPS growth of 20–25%.

$ARMKMed

Aramark Boosts FY26 Organic Revenue Growth - Update

Aramark (ARMK) reported third-quarter results and reaffirmed its FY2026 adjusted EPS growth outlook of 20% to 25%. It raised its FY2026 organic revenue growth forecast to 9% to 10% from the prior high-end 7% to 9%. The board approved a $0.12 quarterly dividend payable Sept. 9, 2026. ARMK was about $55 premarket.

$ARMKMed

Aramark (NYSE:ARMK) Surprises With Q2 CY2026 Sales

Aramark (NYSE:ARMK) reported Q2 CY2026 revenue of $5.06 billion, up 9.3% year over year and 2.4% above Wall Street estimates, according to the company. Non-GAAP adjusted EPS was $0.52, up from $0.40 a year earlier, beating consensus by 7.2%. Analysts expect full-year EPS to rise to $2.57 from $2.09.

$ARMKMedAI 8/10

Aramark (ARMK) – Investment Analysts’ Weekly Ratings Updates

Aramark (NYSE: ARMK) saw multiple brokerages update ratings and price targets from mid-March to mid-May 2026. Bank of America raised its target to $59 (buy); RBC to $55 (outperform); Morgan Stanley to $50 (equal weight); UBS to $56 (buy); JPMorgan to $55 (overweight). Several others reaffirmed “buy” ratings. Aramark also declared a $0.12 quarterly dividend (ex-date May 20), $0.48 annualized, ~0.9% yield.